Who owns Rapt Therapeutics Inc?
- Ticker: RAPT
- CUSIP Number: 75382e109
Tip: Access positions for across all investors
Analyze quarterly positions in Rapt Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rapt Therapeutics stock
Who bought or sold Rapt Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| T. Rowe Price Associates | 3.4M | $85M | -4% | Dec 2023 |
|
| Column Group | 2.7M | $67M | 0% | Dec 2023 |
|
| Perceptive Advisors | 2.1M | $53M | 11% | Dec 2023 |
|
| Vanguard Group | 2.1M | $51M | 2% | Dec 2023 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.1M | $27M | -25% | Dec 2023 |
|
| Kingdon Capital Management | 966k | $24M | 20% | Dec 2023 |
|
| Samlyn Capital | 712k | $18M | 100% | Dec 2023 |
|
| Euclidean Capital | 658k | $16M | 0% | Dec 2023 |
|
| Alphabet | 540k | $13M | 0% | Dec 2023 |
|
| TimesSquare Capital Management | 504k | $13M | 100% | Dec 2023 |
|
| Cormorant Asset Management | 497k | $12M | 53% | Dec 2023 |
|
| Dimensional Fund Advisors | 488k | $12M | -17% | Dec 2023 |
|
| Millennium Management | 465k | $12M | -10% | Dec 2023 |
|
| Citadel Advisors | 394k | $9.8M | 3% | Dec 2023 |
|
| Braidwell | 389k | $9.7M | -64% | Dec 2023 |
|
| Redmile Group | 367k | $9.1M | -14% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 313k | $7.8M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 292k | $7.3M | 100% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 290k | $7.2M | 1761% | Dec 2023 |
|
| OrbiMed Advisors | 281k | $7.0M | -77% | Dec 2023 |
|
| Ubs Global Asset Management Americas | 276k | $6.9M | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 234k | $5.8M | 6% | Dec 2023 |
|
| Fred Alger Management | 228k | $5.7M | 166% | Dec 2023 |
|
| Caption Management | 201k | $5.0M | 100% | Dec 2023 |
|
| Goldman Sachs Group | 196k | $4.9M | 10% | Dec 2023 |
|
| Polar Securities | 194k | $4.8M | -59% | Dec 2023 |
|
| TD Asset Management | 118k | $2.9M | -23% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 111k | $2.7M | -18% | Dec 2023 |
|
| Norges Bank Investment Management | 100k | $2.5M | 100% | Dec 2023 |
|
| Bank of America Corporation | 93k | $2.3M | 1% | Dec 2023 |
|
| Bank of New York Mellon | 92k | $830k | -9% | Mar 2024 |
|
| Point72 Asset Management | 91k | $2.3M | -60% | Dec 2023 |
|
| UBS Group | 90k | $2.2M | 162% | Dec 2023 |
|
| Barclays | 79k | $1.9M | 46% | Dec 2023 |
|
| Jane Street | 76k | $1.9M | 79% | Dec 2023 |
|
| Two Sigma Advisers | 64k | $1.6M | 8% | Dec 2023 |
|
| Ikarian Capital | 59k | $1.5M | 100% | Dec 2023 |
|
| Simplex Trading | 52k | $468k | 100% | Mar 2024 |
|
| Thomas Stevens, CFA" | 51k | $457k | 443% | Mar 2024 |
|
| Jasper Ridge Partners | 46k | $1.1M | 0% | Dec 2023 |
|
| Hennion & Walsh Asset Management | 45k | $401k | 2% | Mar 2024 |
|
| Swiss National Bank | 44k | $1.1M | -10% | Dec 2023 |
|
| Rhumbline Advisers | 43k | $1.1M | 0% | Dec 2023 |
|
| Citigroup | 39k | $974k | -6% | Dec 2023 |
|
| Credit Suisse | 37k | $930k | 11% | Dec 2023 |
|
| Algert Coldiron Investors | 35k | $873k | -43% | Dec 2023 |
|
| Exchange Traded Concepts | 34k | $304k | 371% | Mar 2024 |
|
| Two Sigma Investments | 33k | $811k | 72% | Dec 2023 |
|
| Denali Advisors | 33k | $293k | 100% | Mar 2024 |
|
| Alliancebernstein | 31k | $768k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 26k | $652k | -1% | Dec 2023 |
|
| ALPS Advisors | 23k | $577k | -8% | Dec 2023 |
|
| State of Wisconsin Investment Board | 23k | $562k | -17% | Dec 2023 |
|
| Marshall Wace | 22k | $550k | 100% | Dec 2023 |
|
| Legal & General Group | 21k | $521k | 0% | Dec 2023 |
|
| Mirae Asset Global Investments | 21k | $512k | 0% | Dec 2023 |
|
| GSA Capital Partners | 20k | $508k | -33% | Dec 2023 |
|
| Artia Global Partners | 20k | $488k | 100% | Dec 2023 |
|
| Henderson Group | 16k | $398k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 16k | $391k | 0% | Dec 2023 |
|
| Concurrent Investment Advisors | 15k | $370k | 100% | Dec 2023 |
|
| American International | 15k | $365k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 13k | $310k | -56% | Dec 2023 |
|
| New York State Common Retirement Fund | 12k | $287k | -1% | Dec 2023 |
|
| Chesapeake Capital Corp | 10k | $254k | 100% | Dec 2023 |
|
| SG Americas Securities | 9.8k | $244k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 9.3k | $231k | 116% | Dec 2023 |
|
| Principal Financial Group | 8.9k | $221k | 100% | Dec 2023 |
|
| Florida State Board of Administration | 8.5k | $212k | 100% | Dec 2023 |
|
| ADAR1 Capital Management | 7.5k | $186k | 100% | Dec 2023 |
|
| Virtus ETF Advisers | 4.8k | $119k | 2% | Dec 2023 |
|
| Zurcher Kantonalbank | 4.7k | $42k | 19% | Mar 2024 |
|
| China Universal Asset Management | 4.0k | $99k | 348% | Dec 2023 |
|
| Summit Investment Advisors | 2.9k | $72k | 0% | Dec 2023 |
|
| Cubist Systematic Strategies | 2.7k | $66k | 100% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.9k | $47k | 0% | Dec 2023 |
|
| Amalgamated Bank | 910.00 | $8.0k | -75% | Mar 2024 |
|
| Advisor Group Holdings | 791.00 | $20k | 284% | Dec 2023 |
|
| Daiwa Securities Group | 101.00 | $3.0k | 0% | Dec 2023 |
|
| Cutler | 100.00 | $0 | 100% | Mar 2024 |
|
| CWM | 64.00 | $1.0k | 191% | Mar 2024 |
|
| GAMMA Investing | 27.00 | $242.001000 | 17% | Mar 2024 |
|
| Us Bancorp | 11.00 | $273.000200 | 0% | Dec 2023 |
|
| NISA Investment Advisors | 9.00 | $224.000100 | -62% | Dec 2023 |
|
| Farther Finance Advisors | 2.00 | $50.000000 | 100% | Dec 2023 |
|
Who sold out of Rapt Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boxer Capital | Sep 2023 | 300k | $5.0M |
| Weiss Multi-strategy Advisers | Dec 2023 | 170k | $4.2M |
| Cheyne Capital Management | Sep 2023 | 20k | $332k |
| Allianz Asset Management | Sep 2023 | 18k | $301k |
| J. Goldman & Co | Sep 2023 | 14k | $224k |
| Russell Investments | Sep 2023 | 581.00 | $9.7k |
| Signature | Sep 2023 | 33.00 | $548.001300 |